News Center

Fitch maintains BP’s ’A+’ rating with stable outlook

Fitch maintains BP’s ’A+’ rating with stable outlook

Investing.com -- Fitch Ratings has confirmed BP plc (LON:BP)’s Long-Term Issuer Default Rating (IDR) at ’A+’ and maintained a Stable Outlook on Friday. The rating is based on BP (NYSE:BP)’s commitment to reduce its net debt to between $14 billion and $18 billion by 2027, and the expectation that the company will decrease its EBITDA net leverage to 1.1x-1.2x by 2027 from a high of 1.5x an ...

2025-05-24 02:36:31
Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.72%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.72%

Investing.com – Denmark stocks were lower after the close on Friday, as losses in the Technology, Healthcare and Personal & Household Goods sectors led shares lower.At the close in Copenhagen, the OMX Copenhagen 20 declined 0.72%.The best performers of the session on the OMX Copenhagen 20 were NKT Holding (CSE:NKT), which rose 1.82% or 9.50 points to trade at 531.50 at the close. Meanwhile, ...

2025-05-24 02:35:22
Turkey stocks lower at close of trade; BIST 100 down 1.26%

Turkey stocks lower at close of trade; BIST 100 down 1.26%

Investing.com – Turkey stocks were lower after the close on Friday, as losses in the Sports, Banking and Metal Products & Machinery sectors led shares lower.At the close in Istanbul, the BIST 100 fell 1.26%.The best performers of the session on the BIST 100 were Can2 Termik AS (IS:CANTE), which rose 5.56% or 0.09 points to trade at 1.71 at the close. Meanwhile, Pasifik Eurasia Lojistik Di ...

2025-05-24 02:33:59
GSK’s asthma drug wins FDA approval to treat ’smoker’s lung’

GSK’s asthma drug wins FDA approval to treat ’smoker’s lung’

By Siddhi Mahatole and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration has approved British drugmaker GSK’s asthma drug to treat some patients with a chronic lung disease commonly known as "smoker’s lung", the company said on Thursday. The approval expands the use of the drug, Nucala, as an add-on treatment for patients with a type of chronic obstructive pulmonary disease. Sanof ...

2025-05-24 02:31:56